Literature DB >> 25931269

Promoter DNA methylation is associated with KLF11 expression in epithelial ovarian cancer.

Guan Wang1, Xianfeng Li2, Weiping Tian3, Yan Wang4, Dandan Wu1, Zhongsheng Sun5, Enfeng Zhao6.   

Abstract

As a transforming growth factor-β (TGF-β)-inducible gene, the expression of Krüppel-like transcription factor 11 (KLF11) is altered in several types of cancer. In the current study, through using human 9K CpG island array, KLF11 was identified as one of hypermethylated genes in RAS-transformed ovarian T29H cells. Methylation of the KLF11 promoter was also observed in ovarian cancer tissue samples accompanied by significantly reduced KLF11 gene expression. Interestingly, the expression of SMAD2, SMAD3, and SMAD7 genes was reduced in the tumour, whilst no change was found in TGF-β expression. Our data suggest a relationship between promoter DNA methylation and KLF11 gene expression in ovarian cancer tumorigenesis.
© 2015 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25931269     DOI: 10.1002/gcc.22257

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  6 in total

Review 1.  Methylation and ovarian cancer: Can DNA methylation be of diagnostic use?

Authors:  Julie L Hentze; Claus K Høgdall; Estrid V Høgdall
Journal:  Mol Clin Oncol       Date:  2019-01-11

2.  Phenotypic Characterization of Mice Carrying Homozygous Deletion of KLF11, a Gene in Which Mutations Cause Human Neonatal and MODY VII Diabetes.

Authors:  Angela Mathison; Carlos Escande; Ezequiel Calvo; Seungmae Seo; Thomas White; Ann Salmonson; William A Faubion; Navtej Buttar; Juan Iovanna; Gwen Lomberk; Eduardo N Chini; Raul Urrutia
Journal:  Endocrinology       Date:  2015-08-06       Impact factor: 4.736

Review 3.  Epigenetic Biomarkers in the Management of Ovarian Cancer: Current Prospectives.

Authors:  Alka Singh; Sameer Gupta; Manisha Sachan
Journal:  Front Cell Dev Biol       Date:  2019-09-19

4.  KLF7: a new candidate biomarker and therapeutic target for high-grade serous ovarian cancer.

Authors:  Marta De Donato; Gabriele Babini; Simona Mozzetti; Marianna Buttarelli; Alessandra Ciucci; Gloria Arduini; Maria Cristina De Rosa; Giovanni Scambia; Daniela Gallo
Journal:  J Exp Clin Cancer Res       Date:  2020-11-30

Review 5.  The Distinct Roles of Transcriptional Factor KLF11 in Normal Cell Growth Regulation and Cancer as a Mediator of TGF-β Signaling Pathway.

Authors:  Lili Lin; Sven Mahner; Udo Jeschke; Anna Hester
Journal:  Int J Mol Sci       Date:  2020-04-22       Impact factor: 5.923

6.  KLF11 Expression Predicts Poor Prognosis in Glioma Patients.

Authors:  Zhuo Xi; Rui Zhang; Furong Zhang; Shuang Ma; Tianda Feng
Journal:  Int J Gen Med       Date:  2021-06-28
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.